SYRA

Syra Health Corp. Class A Common Stock

SYRA

Market cap $1.24M

Overview Fund Activity

Delisted

SYRA was delisted on the 17th of April, 2025.

Back to rankings

About: Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.

Employees: 162

Industrials Staffing & Employment Services

Financial journalist opinion

Syra Health Announces Second Quarter Financial Results, Advancing Toward Profitability on Margin Gains and Cost Reductions

- Revenue of $1.9 Million consistent with the year-ago period - Revenue led by Population Health's growth up 197% compared to Q2 2024 - Gross Margin increases to 38.7%, up 2,090 basis points compared to Q2 2024 - Earnings per share for the second quarter of 2025 were ($0.01), compared to ($0.21) in the year-ago period CARMEL, Ind. , Aug. 12, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the second quarter ended June 30, 2025.

Syra Health Announces Second Quarter Financial Results, Advancing Toward Profitability on Margin Gains and Cost Reductions

Syra Health To Announce Second Quarter 2025 Financial Results

CARMEL, Ind. , Aug. 5, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for the three months ended June 30, 2025, on Tuesday, August 12, 2025.

Syra Health To Announce Second Quarter 2025 Financial Results

Syra Health Secures Contract Valued at Up to $2.1 Million to Provide Medical Management Nurses for Major Insurance Provider

CARMEL, Ind. , July 17, 2025 /PRNewswire/ -- Syra Health (OTCQB: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today it has been awarded a new contract with a major insurance provider to staff registered nurses to support specific health plans.

Syra Health Secures Contract Valued at Up to $2.1 Million to Provide Medical Management Nurses for Major Insurance Provider

Syra Health Earns ISO 27001:2022 Certification, Highlighting Company's Commitment to Data Protection

CARMEL, Ind. , July 8, 2025 /PRNewswire/ -- Syra Health (OTCQB: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today it has achieved ISO 27001 certification, the international standard for managing information security.

Syra Health Earns ISO 27001:2022 Certification, Highlighting Company's Commitment to Data Protection

Syra Health Selected for $5.8 Million Indiana Child Mental Health Program

CARMEL, Ind. , May 27, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that the Indiana Department of Administration in collaboration with the Family and Social Services Administration/Division of Mental Health and Addiction has recommended Syra Health for contract negotiations to implement Indiana's Child Mental Health Wraparound Access Site.

Syra Health Selected for $5.8 Million Indiana Child Mental Health Program

Syra Health Board Begins CEO Search to Drive Growth

CARMEL, Ind. , May 20, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that its Board of Directors will begin a national search for a new Chief Executive Officer to succeed current CEO Dr. Deepika Vuppalanchi.

Syra Health Board Begins CEO Search to Drive Growth

Syra Health Corp. (SYRA) Q1 2025 Earnings Call Transcript

Syra Health Corp. (OTC:SYRA) Q1 2025 Earnings Conference Call May 8, 2025 9:00 AM ET Company Participants Corbin Woodhull - Hayden Investor Relations Dr. Deepika Vuppalanchi - Chief Executive Officer Priya Prasad - Chief Financial Officer Conference Call Participants Operator Good morning, ladies and gentlemen. And welcome to the Syra Health First Quarter 2025 Earnings Conference Call.

Syra Health Corp. (SYRA) Q1 2025 Earnings Call Transcript

Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY

Revenue increase led by Population Health's 261% YoY Expansion Gross Margin Improves Substantially to 31.7%, up 14.6 Percentage Points YoY Continued Efficiency Gains Cut Q1 2025 Net Losses by Over Two Thirds Compared to Q1 2024 A conference call will be held today, Thursday, May 8, at 9:00 am ET CARMEL, Ind. , May 8, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today its financial results for the first quarter ended March 31, 2025.

Syra Health Announces First Quarter Revenue of $1.9 Million, Up 6% YoY

Syra Health To Discuss First Quarter 2025 Financial Results

Conference call will be held on Thursday, May 8, at 9:00 a.m. ET CARMEL, Ind.

Syra Health To Discuss First Quarter 2025 Financial Results

Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market

CARMEL, Ind., April 1, 2025 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through innovative technology products and services, announced today that it has given formal notice to the Nasdaq Stock Market of its intention to voluntarily delist its common stock from the Nasdaq Capital Market.

Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market

See News Rankings

Charts implemented using Lightweight Charts™